Tilray Brands, Inc. TLRY
Set alert
At close · Oct 30
After hours · Oct 30, 7:57 PM ET
- YTD
- -71.98%
- 1 year
- -80.39%
- Open
- 2.64
- Prev close
- 2.64
- Mkt cap
- 373.90M
- Vol
- 4.93M
- Avg vol
- 4.05M
- EPS
- -1.41
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.49
- High
- 2.66
- Forward P/E
- -11.61
- Beta
- 2.10
- Short ratio
- 1.71
- Inst. own
- 10.35%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.37
- 200-d avg
- 0.8491
- 1y target
- 1.78
5D chart
Signals (64)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 3:05 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:35 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:30 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 1:05 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:55 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:25 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:00 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:45 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:40 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 3:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:25 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 1:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:05 PM | 3 days ago |
| SMA: Bullish | Oct 29, 11:55 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:55 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:50 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:45 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:00 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:35 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 9:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:25 AM | 4 days ago |
| RSI: Oversold | Oct 28, 11:10 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:55 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 9:30 AM | 4 days ago |
| RSI: Oversold | Oct 28, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:40 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:15 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:50 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:50 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:55 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:40 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:15 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 10:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:15 AM | 5 days ago |
| RSI: Overbought | Oct 27, 9:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:10 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:45 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:30 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:20 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 12:45 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 12:40 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 12:30 PM | 6 days ago |
| RSI: Oversold | Oct 26, 12:00 PM | 6 days ago |
| SMA: Bullish | Oct 26, 10:35 AM | 6 days ago |
News
3 hours ago fool.com
Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing
Tilray Brands has shifted from a marijuana company to a global brand manager across marijuana, beverages, and wellness. The company's fiscal first quarter 2027 earnings highlight just how much the…
17 hours ago fool.com
Tilray Just Posted Record Quarterly Revenue of $257 Million. So Why Did Its Cannabis Sales Shrink?
Tilray reported record quarterly revenue of $257.1 million. Cannabis revenue declined 13% despite strong international growth.
2 days ago fool.com
Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
Canopy Growth (CGC -4.34%) primarily generates revenue by selling medical and recreational cannabis products to consumers across several international regions.
-
3 days ago benzinga.com
Tilray Brands Targets $20M In Annualized Cost Savings Through FY28; Plans Disposal Of Several Brewing And Warehouse Facilities; Reaffirms FY27 Adjusted EBITDA Guidance Of $68M-$75M
Successfully Completed Consolidation of U.S. Brewing Footprint from 10 Facilities to SixIdentifying Further Opportunities to Reduce Complexity, Improve Brewery Utilization and Strengthen…
3 days ago globenewswire.com
Tilray Brands Announces Next Phase of Beverage Transformation
Successfully Completed Consolidation of U.S. Brewing Footprint from 10 Facilities to Six Identifying Further Opportunities to Reduce Complexity, Improve Brewery Utilization and Strengthen Margins…
5 days ago fool.com
Down 70% in 2026, Has Tilray's Stock Finally Bottomed Out?
Tilray's low valuation may be enticing to investors as its market cap is just $400 million. The business, however, struggles to grow organically on a consistent basis.
1 week ago fool.com
Tilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors.
Tilray started out as a pure-play marijuana company. The company has since decided to shift toward a consumer staples approach, selling branded products beyond pot.
1 week ago globenewswire.com
Blue Point Brewing Co.'s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews
PATCHOGUE, N.Y., Oct. 22, 2026 (GLOBE NEWSWIRE) -- One of Long Island's longest-running craft beer celebrations is returning to Main Street.
1 week ago globenewswire.com
West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers
ELLON, Scotland and LONDON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- BrewDog , a leader in U.K. craft beer and one of the world's most recognised beer brands, owned by Tilray Brands, Inc. (NASDAQ: TLRY;…
-
1 week ago benzinga.com
Tilray’s Q1 Results Show A Company Transformed
Tilray Brands, Inc. (NASDAQ:TLRY) opened fiscal 2027 with the strongest first quarter in its history, reporting record revenue of $257.1 million, up 23% from a year ago. Gross profit set a…
2 weeks ago defenseworld.net
Tilray Brands (TSE:TLRY) Sets New 52-Week Low – Here’s Why
Tilray Brands, Inc. (TSE: TLRY - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Wednesday. The stock traded as low as C$4.61 and last traded at C$4.64, with a volume…
2 weeks ago fool.com
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
Canopy Growth maintains a strategic focus on premium cannabis products and European medical distribution. Tilray Brands has expanded into the craft beverage and wellness markets to diversify its…
2 weeks ago globenewswire.com
SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia
Crack Open the Good Times: Fans 21+ Can Scan the SweetWater QR Code in or Enter Online for a Shot at a Night Out at Georgia Theatre, The Eastern, Variety Playhouse, or Terminal West Crack Open the…
-
2 weeks ago benzinga.com
Tilray Brands’ Unit Tilray Medical Secures Key Regulatory Approval For In-House Testing At Portugal Facility
Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), today…
2 weeks ago globenewswire.com
Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
CANTANHEDE, Portugal, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray…
2 weeks ago seekingalpha.com
BrewDog Acquisition Boosts Tilray's Q1 Performance
Tilray reported Q1-2027 financial results last week with increasing revenue from its BrewDog operations; Cannabis revenue decreased. The company expects its new beer assets along with its…
2 weeks ago seekingalpha.com
Tilray Q1: Not Looking Good, Remains A 'Hold'
Tilray reported disappointing fiscal Q1 results, missing revenue estimates despite management highlighting record sales. TLRY's revenue growth was driven solely by the BrewDog acquisition; core…
2 weeks ago fool.com
3 Huge Red Flags From Tilray's Q1 Earnings Report
Tilray's cash burn continues to be a big problem for investors. The business has been growing through acquisitions, and while that can boost the top line, it can also lead to significantly higher…
3 weeks ago fool.com
Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?
Canopy Growth is refining its focus on medical and adult-use markets while managing its U.S. expansion strategy through Canopy USA. Tilray Brands has diversified its revenue stream significantly…
3 weeks ago fool.com
3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices
Tilray's financial results have been weak for years. The company operates in an uncertain industry.
-
3 weeks ago benzinga.com
Canaccord Genuity Maintains Hold on Tilray Brands, Lowers Price Target to $4
Canaccord Genuity analyst Kenric Tyghe maintains Tilray Brands (NASDAQ:TLRY) with a Hold and lowers the price target from $4.5 to $4.
3 weeks ago marketbeat.com
Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
Tilray Brands TodayTLRYTilray Brands$3.44 -0.15 (-4.04%) As of 11:26 AM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$3.38▼$20.20Price Target$6.38Add to…
3 weeks ago seekingalpha.com
Tilray Brands, Inc. (TLRY) Q1 2027 Earnings Call Transcript
Tilray Brands, Inc. (TLRY) Q1 2027 Earnings Call Transcript
3 weeks ago marketbeat.com
Tilray Brands Q1 Earnings Call Highlights
Tilray Brands NASDAQ: TLRY reported record first-quarter revenue and gross profit, driven by its BrewDog acquisition, international cannabis growth and pharmaceutical distribution operations, while…
3 weeks ago proactiveinvestors.com
Tilray revenue rises as beverage business drives record quarterly sales
Tilray Inc (NASDAQ:TLRY), the cannabis and consumer products company, reported record first-quarter revenue of $257.1 million, up 23% from a year earlier, driven by strong growth in beverages and…
3 weeks ago benzinga.com
Tilray Brands Q1 2027 Earnings Call Transcript
Tilray Brands (NASDAQ:TLRY) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below. Benzinga APIs provide…
3 weeks ago benzinga.com
Earnings Scheduled For October 8, 2026
Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is likely to report quarterly loss at $0.15 per share on revenue of $266.42 million. • Helen Of Troy (NASDAQ:HELE) is projected to…
-
3 weeks ago benzinga.com
Tilray Brands Q1 Adj. EPS $(0.02) Beats $(0.20) Estimate, Sales $257.147M Miss $267.813M Estimate
Tilray Brands (NASDAQ:TLRY) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.20) by 90 percent. The company reported quarterly sales of $257.147 million…
-
3 weeks ago benzinga.com
Tilray Brands Q1 Adj. EPS $(0.02) Beats $(0.20) Estimate, Sales $257.147M Miss $267.464M Estimate
Tilray Brands (TSX:TLRY) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.20) by 90 percent. The company reported quarterly sales of $257.147 million…
3 weeks ago benzinga.com
PepsiCo, Levi Strauss And 3 Stocks To Watch Heading Into Thursday
Stocks in focus: Applied Digital beat Q1 estimates; Levi posted mixed results. Investors await earnings from Helen of Troy, PepsiCo and Tilray.
3 weeks ago benzinga.com
Dow Falls Over 300 Points As Treasury Yields Surge: Investor Sentiment Weakens, Fear & Greed Index Remains In ‘Neutral’ Zone
Market sentiment slipped but stayed neutral as U.S. stocks fell amid rising Treasury yields; mortgage applications declined for a fifth week.
3 weeks ago benzinga.com
Stock Market: Will S&P 500 Open Up or Down Today?
Will S&P 500 open higher? Polymarket odds sit at 52% as Wall Street weighs 5.35% Treasury yields, potential Iran strikes, and Pepsi earnings.
4 weeks ago benzinga.com
PepsiCo Could Swing $6.46 Billion In Value After Earnings
Earnings season is set to bring heightened volatility, with PepsiCo, Constellation Brands, Delta Air Lines, Applied Digital and Tilray Brands facing potentially sharp post-earnings moves as options…
-
1 month ago benzinga.com
'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment
https://www.marijuanamoment.net/dea-judge-pauses-marijuana-rescheduling-hearing-as-opponents-highlight-government-report-detailing-gaps-in-federal-processes/
-
2 months ago benzinga.com
Tilray Brands Launches Major Expansion Of Its Global Cannabis Cultivation Capacity To Meet Accelerating International Medical Cannabis Demand
Tilray has increased annual cultivation capacity at its Quebec facility by 30 metric tonnes, materially increasing inventory for the Quebec market while adding supply for Europe, Australia and other…
3 months ago benzinga.com
6 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
3 months ago benzinga.com
Tilray Brands (TLRY) Stock Is Trending: Here's What You Should Know
Tilray Brands shares jumped 2.23% after hours as quarterly revenue beat estimates, despite earnings per share missing expectations.
-
3 months ago benzinga.com
Tilray Brands Q4 Adj. EPS $0.05 Beats $(0.01) Estimate, Sales $281.714M Beat $246.377M Estimate
Tilray Brands (TSX:TLRY) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.01) by 600 percent. This is a 75 percent decrease over earnings of $0.20 per…
-
3 months ago benzinga.com
TD Cowen Maintains Buy on Tilray Brands, Lowers Price Target to $5
TD Cowen analyst Robert Moskow maintains Tilray Brands (NASDAQ:TLRY) with a Buy and lowers the price target from $7 to $5.
-
3 months ago benzinga.com
Tilray Medical Rolls Out Its First Medical Cannabis Product In Panama
Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) and a leading global medical cannabis company, today announced the commercial launch of its first medical cannabis product in…
-
4 months ago benzinga.com
Tilray Brands To Acquire HelloMD Corporation; Financial Terms Not Disclosed
Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) ("Tilray"), a global leader in medical cannabis, today announced the acquisition of HelloMD Corporation, a digital healthcare and patient engagement…
4 months ago benzinga.com
Trulieve Makes History As First US Cannabis Stock On NYSE
https://www.benzinga.com/markets/equities/26/06/53113507/trump-says-iran-took-too-long-and-will-pay-the-price-markets-already-are
-
4 months ago benzinga.com
Tilray Launches ARX, Its First Premium Medical Cannabis Brand Developed And Cultivated In Germany
The introduction of ARX marks a significant step forward in the quality of medical cannabis available in Germany and reflects more than two years of development at the Aphria RX facility in…
-
4 months ago benzinga.com
'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment
https://www.marijuanamoment.net/white-house-pushes-congress-to-keep-hemp-cbd-products-legal-by-amending-broad-ban-thats-set-to-take-effect-later-this-year/
-
5 months ago benzinga.com
"Marijuana Components Have 'Consistent' Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows" - Marijuana Moment
https://www.marijuanamoment.net/marijuana-components-have-consistent-anti-tumor-effec
6 months ago benzinga.com
Why Akanda Stock Is Surging Wednesday?
Akanda Corp. (NASDAQ: AKAN) stock surges over 50% Wednesday. Learn how DOJ regulatory shifts and low float dynamics are driving the rally.
6 months ago benzinga.com
Akanda Shares Soar As Cannabis Stocks Rise On US Policy Change
Akanda stock surges as U.S. moves to reclassify marijuana, lifting cannabis stocks and fueling strong momentum.
6 months ago benzinga.com
Tilray Smells Opportunity After Historic Cannabis Policy Shift
Tilray Brands eyes U.S. expansion as cannabis reclassification to Schedule III creates new opportunities for growth and clinical research.
6 months ago benzinga.com
What's Going On With SoFi Technologies Stock Thursday?
SoFi Technologies faces volatility ahead of April 29 earnings. Read our technical breakdown, key support levels, and analyst consensus.
-
6 months ago benzinga.com
'Trump Reclassifies State-Licensed Medical Marijuana As A Less-Dangerous Drug In A Historic Shift' - AP News
https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3aae122b1a91f8e4b6c690268